In:
Healthcare, MDPI AG, Vol. 10, No. 10 ( 2022-09-28), p. 1898-
Abstract:
The development of new systemic treatment strategies has resulted in a significant increase in the response rates of colorectal liver metastases (CRLM) in the last few years. Although the radiological response is a favorable prognostic factor, complete shrinkage of CRLM, known as disappearing liver metastases (DLM), presents a therapeutic dilemma, and proper management is still debated in the literature. In fact, DLM is not necessarily equal to cure, and when resected, pathological examination reveals in more than 80% of patients a variable percentage of the tumor as residual disease or early recurrence in situ. Moreover, while a higher incidence of intrahepatic recurrence is documented in small series when surgery is avoided, its clinical significance for long-term OS is still under investigation. In light of this, a multidisciplinary approach and, in particular, radiologists’ role is needed to assist the surgeon in the management of DLM, thanks to emerging technology and strategy. Therefore, the aim of this review is to provide an overview of the DLM phenomenon and current management.
Type of Medium:
Online Resource
ISSN:
2227-9032
DOI:
10.3390/healthcare10101898
Language:
English
Publisher:
MDPI AG
Publication Date:
2022
detail.hit.zdb_id:
2721009-1
Permalink
